G-test Portfolio Expansion
Gastrointestinal Diseases
DevelopmentActive
Key Facts
About Genloxa
Genloxa is a private, revenue-generating diagnostics laboratory focused on personalized medicine in gastroenterology and oncology. Its core offerings include proprietary 'G-tests' for fecal biomarkers (calprotectin, pancreatic elastase) and the Dose5-FU test, the only service in Poland for monitoring 5-fluorouracil levels during chemotherapy to personalize dosing. The company targets both individual patients and institutional clients like hospitals, leveraging EU-funded R&D projects to expand its test menu and laboratory capabilities. Its strategy centers on providing rapid, non-invasive diagnostics to accelerate treatment decisions and improve therapeutic outcomes.
View full company profileTherapeutic Areas
Other Gastrointestinal Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| LAPS GLP-1/GLP-2 Dual Agonist | Zealand Pharma | Preclinical |